What is 3-oxohexadecanoic Acid Glyceride?
3-oxohexadecanoic acid glyceride (CAS Number: 128331-46-4) is a synthetic organic compound belonging to the class of fatty acid derivatives. The compound consists of a glyceride structure with a 16-carbon fatty acid chain containing a ketone functional group at the third carbon position (hence "3-oxo"). This specific chemical structure is designed to function as a flavoring agent in food manufacturing.
The compound is produced through chemical synthesis rather than extraction from natural sources, classifying it as a synthetic flavoring ingredient. Its molecular composition allows it to interact with taste receptors and contribute to flavor profiles in finished food products.
Common Uses
3-oxohexadecanoic acid glyceride is employed in the food industry as a flavoring agent or flavoring adjuvant. Flavoring adjuvants are compounds that don't directly provide taste or aroma themselves but enhance, modify, or stabilize the perception of existing flavors in food products. This ingredient may be used in various processed foods where flavor enhancement or modification is desired, though specific product applications vary by manufacturer and regional regulatory allowances.
The concentration levels used in food products are typically very low, as is standard practice with synthetic flavoring agents. Its inclusion in formulations is determined by food technologists based on desired sensory outcomes and regulatory compliance in target markets.
Safety Assessment
According to FDA records, there have been zero adverse events reported in connection with 3-oxohexadecanoic acid glyceride, and zero FDA recalls involving this ingredient. This absence of reported safety incidents suggests no acute toxicity or immediate health concerns have been documented through consumer use or regulatory monitoring.
The compound has not received GRAS (Generally Recognized As Safe) status from the FDA, which means it has not undergone the formal FDA GRAS affirmation process. GRAS status is one pathway for ingredient approval but is not the only regulatory mechanism for food additives. The lack of GRAS designation does not indicate the ingredient is unsafe; rather, it indicates the specific regulatory pathway used for this additive differs from GRAS notification.
Synthetic flavoring compounds undergo safety evaluation before market approval in regulated jurisdictions. Standard toxicological assessments for such compounds typically evaluate acute toxicity, repeat-dose toxicity, genotoxicity, and allergenicity potential. The chemical structure of 3-oxohexadecanoic acid glyceride—as a fatty acid derivative—suggests a profile generally consistent with other food-approved lipid-based ingredients, though specific safety dossiers would contain detailed toxicological data.
Regulatory Status
Regulatory approval and use permissions for 3-oxohexadecanoic acid glyceride vary by jurisdiction. In countries with established food additive regulatory frameworks, this ingredient's status, permitted uses, and maximum usage levels are defined by local food safety authorities. Food manufacturers must comply with regulations in markets where their products are sold.
The ingredient's regulatory classification as a flavoring agent places it within established frameworks for synthetic flavor compounds, which typically allow for lower concentrations in food compared to direct additives like colorants or preservatives.
Key Studies
Public literature specifically focused on 3-oxohexadecanoic acid glyceride as an isolated compound is limited. Safety data for this ingredient is primarily proprietary, held by manufacturers and submitted to regulatory authorities during approval processes. General toxicological information on structurally similar fatty acid glycerides provides context for safety assessment, as regulatory bodies evaluate new compounds partially based on structure-activity relationships with known safe compounds.
Researchers and regulatory agencies may reference safety studies on related compounds to inform risk assessment. The absence of published adverse event literature does not indicate the compound is unstudied; rather, safety documentation typically exists in regulatory submission files not publicly available.